Health and Fitness Health and Fitness
Wed, December 14, 2011
[ Wed, Dec 14th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Synovis Life Technologies, Inc.
[ Wed, Dec 14th 2011 ] - Market Wire
AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
[ Wed, Dec 14th 2011 ] - Market Wire
Orexigen Therapeutics Announces Proposed Public O .. ommon Stock and Warrants to Purchase Common Stock
[ Wed, Dec 14th 2011 ] - Market Wire
Anthera Announces Completion of Safety Review by DSMB for VISTA-16
[ Wed, Dec 14th 2011 ] - Market Wire
Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
[ Wed, Dec 14th 2011 ] - Market Wire
BioSante Pharmaceuticals Announces Results from LibiGel Efficacy Trials
[ Wed, Dec 14th 2011 ] - Market Wire
Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
[ Wed, Dec 14th 2011 ] - Market Wire
Cannabis Science Negotiates Commercialization Dea .. rand Formulations Immediately into the California
[ Wed, Dec 14th 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of Synovis Life Technologies, Inc.
[ Wed, Dec 14th 2011 ] - Market Wire
ViroPharma Announces Approval of Modernized Label .. Vancocin (vancomycin hydrochloride, USP) Capsules
[ Wed, Dec 14th 2011 ] - Market Wire
Positron's Attrius Receives Health Canada Approval
[ Wed, Dec 14th 2011 ] - Market Wire
AIM Honored for Innovative Program That Helps Consumers Make Better Choices About Their Care
[ Wed, Dec 14th 2011 ] - Market Wire
Vooraanstaande samenwerkingsgroep voor lymfoomond .. ) kiest REVLIMID voor onderzoek naar tweede meest
[ Wed, Dec 14th 2011 ] - Market Wire
International Drug & Explosives Detection Company IDenta Corp. Reports Sales
[ Wed, Dec 14th 2011 ] - Market Wire
MSA Fire Service Business Gets Boost From Breathing Apparatus Contracts in U.S., Canada and Chile
[ Wed, Dec 14th 2011 ] - Market Wire
Lilly Recognized as One of the Best Places to Work for LGBT Equality
[ Wed, Dec 14th 2011 ] - Market Wire
Amica Mature Lifestyles Announces Closing of Subs .. cluding Exercise in Full of Over-Allotment Option
[ Wed, Dec 14th 2011 ] - Market Wire
Amgen Announces Final Results of Its Tender Offer
[ Wed, Dec 14th 2011 ] - Market Wire
Tortoise Pipeline & Energy Fund Announces Full Investment and Top Ten Holdings
[ Wed, Dec 14th 2011 ] - Market Wire
Pfizer, Cisco, Walt Disney, Research In Motion, U .. ban Outfitters and Green Mountain Coffee Roasters
[ Wed, Dec 14th 2011 ] - Market Wire
A Change in Tides - Featured Research on Keryx Biopharmaceuticals and AEterna Zentaris Inc. (USA)
[ Wed, Dec 14th 2011 ] - Market Wire
St. Jude Medical annuncia il primo impianto nella .. clinica per la valutazione dalla valvola cardiac
[ Wed, Dec 14th 2011 ] - Market Wire
IntegraMed America Selects Adaptive Planning
[ Wed, Dec 14th 2011 ] - Market Wire
CytoSorbents Awarded US Army SBIR Trauma Grant
[ Wed, Dec 14th 2011 ] - Market Wire
Datos finales de la Fase II que evalan REVLIMID y .. eucemia linfoctica crnica recurrente o resistente
[ Wed, Dec 14th 2011 ] - Market Wire
Definitieve fase 2 gegevens van evaluatie REVLIMI .. et recidiverende of refractaire chronische lymfat
[ Wed, Dec 14th 2011 ] - Market Wire
Premiere Cooperative Group in Adult Lymphoma Rese .. for Study in Second Most Common Lymphoma Subtype
[ Wed, Dec 14th 2011 ] - Market Wire
Salix Pharmaceuticals Announces NDA Submission fo .. emer for the Treatment of HIV-Associated Diarrhea
[ Wed, Dec 14th 2011 ] - Market Wire
Meta-analysis of Five Clinical Trials including C .. T Study Published in American Journal of Obstetri
[ Wed, Dec 14th 2011 ] - Market Wire
REVLIMID evaluado en combinacin con rituximab com .. pacientes con leucemia linfoctica crnica no trata

REVLIMID evaluado en combinacin con rituximab como tratamiento potencial para pacientes con leucemia linfoctica crnica no trata


Published on 2011-12-14 03:22:14 - Market Wire
  Print publication without navigation


BOUDRY, Suiza--([ ])--Celgene International Srl, filial de Celgene Corporation (NASDAQ: CELG), ha anunciado los resultados de un estudio de investigacin que evala REVLIMID (lenalidomida) en combinacin con rituximab en pacientes con leucemia linfoctica crnica no tratados con anterioridad. Estos datos se han presentado en la 53 Reunin Anual de la American Society of Hematology en San Diego (California).

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources